Answers are grounded in this paper and cite their sources.
Reports successful treatment of Staphylococcus aureus endocarditis with reduced vancomycin susceptibility in a pediatric patient, indicating clinical management feasibility.
Infective endocarditis (IE) caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility (SARV) has been reported worldwide. We report the successful treatment of a pediatric patient with SARV IE and characterization of the infecting strain. The MIC of vancomycin rose from 1.5 to 2 microg/ml, and the SARV was confirmed by population analysis.
No takes yet. Share an insight, caveat, or question.
Chi et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: